| Aim at Melanoma (Aim for Answers, Action and the Cure | | Key Melanoma Information Online |
| Article on Skin Cancers Rise, Along With Questionable Treatments |
| Melanoma and Advance Light Source Treatment Links |
| Melanoma Cancer Links |
| Melanoma International Foundation |
| Melanoma Patient's Information Page |
| Melanoma Research Foundation |
| Melanoma Resources |
| Melanoma... What is Melanoma |
MetLife
Skin Cancer Screening: What to Expect |
| Skin Cancer Identification |
| John Wayne Cancer Institute, Melanoma Program |
KentuckyOne Health
James Graham Brown Cancer Center |
| Memorial Sloan-Kettering Cancer Center |
| National Cancer Institute |
The Ohio State University Comprehensive Cancer Center
The James Cancer Hospital and Solove Research Institute |
University of Texas
M. D. Anderson Cancer Center Melanoma and Skin Center |
University of Texas
M. D. Anderson Cancer Center Melanoma Page |
New Blood Test Can Detect Melanoma Better Than a Biopsy - July 17, 2018 |
| FDA Approval of BRAFTOVI™ (encorafenib) in Combination with MEKTOVI® (binimetinib) - June 27, 2018 |
| Common Skin Bacteria May Prevent Skin Cancer - February 28, 2018 |
| Keytruda Improves Survival in Advanced Melanoma Patients Compared to Yervoy, Phase 3 Trial Shows - June 8, 2017 |
| Deep Learning Algorithm Might Change How Skin Cancer Is Diagnosed - January 26, 2017 |
| Treatment Blocking Melanoma Metastasis May Be on the Horizon - December 20, 2016 |
| FDA Expands Nivoluimab"s Frontline Melanoma Approval to Include BRAF-Mutant Patients - January 23, 2016 |
| Are We Winning the Fight Against Melanoma? - January 11, 2016 |
| FDA Approves Vemurafenib and Cobimetinib Combination for Advanced Melanoma - November 11, 2015 |
| FDA Approves Adjuvant Yervoy in Melanoma - October 28, 2015 |
| FDA Approves Talimogene Laherparepvec (T-VEC) for Advanced Melanoma - October 27, 2015 |
| FDA Approves Opdivo and Yervoy Combination for Advanced Melanoma - October 01, 2015 |
| Bristol-Myers Drug Opdivo (Non - Chemo)- November 16, 2014 |
| FDA Approval for Merck's Keytruda - September 4, 2014 |
| Viral Cancer Vaccine Talimogene Laherparepvec (T-Vec) Tackles Melanoma Tumors - March 15, 2014 |
| Lambrolizumab(MK-3475) Show Survival Benefit for Patients With Advanced Melanoma November 19, 2013 |
| Versante (Innovative Systems for the Early Detection of Cancer)- November 12, 2013 |
| FDA Approval for Yervoy (Ipilimumab) - July 3, 2013 |
| FDA Approval for Vemurafenib (BRAF) - July 3, 2013 |
| Drug Combination Against NRAS-Mutant Melanoma Discovered - September 17, 2012 |
| 2 New Drugs (Yervoy/Ipilimumab and Vemurafenib) to Treat Advanced Melanoma - June 6, 2011 |
|
| Return to Home Page |
If any of these links fail, please send me an email from the 'Home Page' and include the link that failed.
|